AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series

One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between th...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddig, Amira, Abbasher Hussien Mohamed Ahmed, Khabab, Hassan Haroun, Mazin S., M. Abdallah, Abdallah, Malekaldar, Mohamed, Abbasher, Al Hussien, Abbasher, Mohammed, Abbasher, Abubaker Alsedig, Hussien, Abbasher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272208/
https://www.ncbi.nlm.nih.gov/pubmed/35846901
http://dx.doi.org/10.1002/ccr3.6017
Descripción
Sumario:One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between the AstraZeneca COVID‐19 vaccine and these conditions.

Ejemplares similares